Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020)

doi:10.1186/s12943-023-01842-7

	Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020)
	2023-08-19
	Zhang, Tao 1; Qu, Rong 1; Chan, Shingpan 2; Lai, Mengzhen 1,3; Tong, Linjiang 1; Feng, Fang 1; Chen, Hongyu 4; Song, Tingting 4; Song, Peiran 1; Bai, Gang1,5,6 ; Liu, Yingqiang 1,3; Wang, Yanan 1; Li, Yan 1; Su, Yi 1; Shen, Yanyan 1; Sun, Yiming 1; Chen, Yi 1; Geng, Meiyu 1; Ding, Ke 2; Ding, Jian 1; Xie, Hua 1
出处	MOLECULAR CANCER
出版者	BMC
DOI	10.1186/s12943-023-01842-7
URL	查看原文
语种	英语
卷号	22
期号	1
收录类别	SCI
WOS类目	Biochemistry & Molecular Biology ; Oncology
WOS研究方向	Biochemistry & Molecular Biology ; Oncology
WOS记录号	WOS:001051507300002
文献类型	其他
条目标识符	https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/325812
专题	生命科学与技术学院生命科学与技术学院_博士生
通讯作者	Ding, Ke; Ding, Jian; Xie, Hua
作者单位	1.Chinese Acad Sci, Shanghai Inst Mat Med, Div Antitumor Pharmacol, State Key Lab Drug Res, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China 2.Jinan Univ, Sch Pharm, Int Cooperat Lab Tradit Chinese Med Modernizat & I, Guangzhou City Key Lab Precis Chem Drug Dev,Chines, 601 Huangpu Ave West, Guangzhou 510632, Peoples R China 3.Fudan Univ, Sch Pharm, 826 Zhangheng Rd, Shanghai 201203, Peoples R China 4.Jiangsu Aosaikang Pharmaceut Co Ltd ASK Pharm, 699 Kejian Rd, Nanjing 211112, Peoples R China 5.Univ Chinese Acad Sci, 19A Yuquan Rd, Beijing 100049, Peoples R China 6.ShanghaiTech Univ, Sch Life Sci & Technol, 393 Middle Huaxia Rd, Shanghai 201210, Peoples R China
推荐引用方式 GB/T 7714	Zhang, Tao,Qu, Rong,Chan, Shingpan,et al. Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance (vol 19, 90, 2020). 2023-08-19.